Steroid pulses for infant lung disease NEHI
Part of Lungs & breathing clinical trials.
This trial tests if giving methylprednisolone (a strong steroid) through an IV can help infants with a rare lung condition called NEHI. The goal is to see if it reduces oxygen needs and improves breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is under 12 months old.
- Your baby has been diagnosed with NEHI (a rare lung condition) using a specific score (Liptzin score) and a CT scan, or a lung biopsy.
- Your baby needs extra oxygen, either when awake or asleep.
- Your baby is being followed at a hospital that is part of the RespiRare network.
- Your baby has not received methylprednisolone (a steroid) through an IV before.
- Your baby does not have diabetes or uncontrolled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
This trial tests a new treatment to help very premature babies (born at 22 to nearly 29 weeks) who still need a breathing machine and extra oxygen at 1–2 weeks old. The goal is to see if it can improve their lung health and reduce the need for breathing support.
This trial tests whether giving intravenous immunoglobulin (IVIG) early after birth can help prevent or treat a serious lung condition called bronchopulmonary dysplasia (BPD) in babies born at 28 weeks or earlier. It may help reduce the need for breathing support and oxygen.
This trial tests whether giving methylprednisolone (a steroid medicine) can lower the body’s inflammatory response in children during the first day after congenital open-heart surgery. It may help reduce harmful inflammation and improve recovery for some children undergoing their first surgery.
This trial tests whether a type of stem cell (mesenchymal stromal cells) can help prevent bronchopulmonary dysplasia, a serious lung condition, in very premature babies. Babies born before 28 weeks who are on a breathing machine with high oxygen needs may be eligible.
This study tests if giving oral steroids (medicine to reduce airway swelling) only when needed based on a child's own biology can help preschool children with wheezing. It aims to find the best treatment for each child, avoiding unnecessary medicine.
Hear when a new Neuroendocrine Cell Hyperplasia of Infancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.